Indication
Staphylococcus aureus septicemia
*Staphylococcus aureus* septicemia is a life-threatening systemic infection characterized by the invasion and active proliferation of the bacterium *Staphylococcus aureus* within the bloodstream, eliciting a dysregulated host immune response. Read more about Staphylococcus aureus septicemia
138 drugs 67 manufacturers
Drugs that treat it
Common Staphylococcus aureus septicemia therapies.
NAFCILLIN SODIUM
DAPTOMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Staphylococcus aureus* septicemia is a life-threatening systemic infection characterized by the invasion and active proliferation of the bacterium *Staphylococcus aureus* within the bloodstream, eliciting a dysregulated host immune response.
It affects multiple organ systems and can occur in both community and healthcare settings, disproportionately impacting hospitalized individuals, those with intravascular devices, and immunocompromised hosts.
Pathophysiologically, the release of staphylococcal toxins, enzymes, and cell-wall components triggers profound systemic inflammation, endothelial damage, hemodynamic instability, and microvascular dysfunction.
Clinically, it presents with fever, tachycardia, hypotension, and altered mental status, carrying a high risk of progression to septic shock and metastatic seeding to distant sites such as the endocardium, bones, and visceral organs.
- nih.gov
*Staphylococcus aureus* septicemia is a life-threatening systemic infection characterized by the invasion and active proliferation of the bacterium *Staphylococcus aureus* within the bloodstream, eliciting a dysregulated host immune response
- medlineplus.gov
*Staphylococcus aureus* septicemia is a life-threatening systemic infection characterized by the invasion and active proliferation of the bacterium *Staphylococcus aureus* within the bloodstream, eliciting a dysregulated host immune response
- nih.gov
It affects multiple organ systems and can occur in both community and healthcare settings, disproportionately impacting hospitalized individuals, those with intravascular devices, and immunocompromised hosts Pathophysiologically, the release of staphylococcal toxins, enzymes, and cell-wall components triggers profound systemic inflammation, endothelial damage, hemodynamic instability, and microvascular dysfunction
- cdc.gov
It affects multiple organ systems and can occur in both community and healthcare settings, disproportionately impacting hospitalized individuals, those with intravascular devices, and immunocompromised hosts
- nih.gov
Pathophysiologically, the release of staphylococcal toxins, enzymes, and cell-wall components triggers profound systemic inflammation, endothelial damage, hemodynamic instability, and microvascular dysfunction
- nih.gov
Clinically, it presents with fever, tachycardia, hypotension, and altered mental status, carrying a high risk of progression to septic shock and metastatic seeding to distant sites such as the endocardium, bones, and visceral organs
- idsociety.org
Clinically, it presents with fever, tachycardia, hypotension, and altered mental status, carrying a high risk of progression to septic shock and metastatic seeding to distant sites such as the endocardium, bones, and visceral organs
Personalize your experience
Follow Staphylococcus aureus septicemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.